SecBot SecBot
SECBOTREPLAY Home › Report › LGND

LGND · Director Martine Zimmermann filed a Form 144 notice of intent to sell…

LIGAND PHARMACEUTICALS INC · 144 filed Nov 12, 2026 at 16:23 ET

At the news

NEUTRALIMPACT 2/10

144 filed Nov 12, 2026 at 16:23 ET

Director Martine Zimmermann filed a Form 144 notice of intent to sell 2,000 shares of Ligand Pharmaceuticals common stock, with an estimated aggregate market value of approximately $636,336. The shares were acquired through restricted stock grants in 2025 and 2026. This is a routine insider sale by a director and represents a small fraction of the company's market cap.

  • Reporting person: Martine Zimmermann, Director of Ligand Pharmaceuticals
  • Securities to be sold: 2,000 shares of Common Stock
  • Estimated aggregate market value: $636,336.20
  • Shares acquired via restricted stock grants on 06/06/2025 (626 shares), 09/22/2025 (647 shares), and 06/05/2026 (727 shares)

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access